↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Landen M) "

Search: WFRF:(Landen M)

Result 261-270 of 375

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
261.	Kyaga, S, et al. (author) Creativity and mental disorder Reply 2012 In: BRITISH JOURNAL OF PSYCHIATRY. - : Royal College of Psychiatrists. - 0007-1250 .- 1472-1465. ; 200:4, s. 348-348 Journal article (other academic/artistic)
262.	Landen, Jaren W., et al. (author) Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study 2017 In: Alzheimer's and Dementia: Translational Research and Clinical Interventions. - : Wiley. - 2352-8737. ; 3:3, s. 393-401 Journal article (peer-reviewed)abstract Introduction The safety, pharmacokinetics, and effect on peripheral and central amyloid β (Aβ) of multiple doses of ponezumab, an anti-Aβ monoclonal antibody, were characterized in subjects with mild-to-moderate Alzheimer's disease treated for 1 year. Methods Subjects were aged ≥50 years with Mini–Mental State Examination scores 16 to 26. Cohort Q was randomized to ponezumab 10 mg/kg (n = 12) or placebo (n = 6) quarterly. Cohort M was randomized to a loading dose of ponezumab 10 mg/kg or placebo, followed by monthly ponezumab 7.5 mg/kg (n = 12) or placebo (n = 6), respectively. Results Ponezumab was generally well tolerated. Plasma concentrations increased dose dependently, but cerebrospinal fluid (CSF) penetration was low. Plasma Aβ increased dose dependently with ponezumab, but CSF biomarkers, brain amyloid burden, cognition, and function were not affected. Conclusions Both ponezumab dosing schedules were generally safe and well tolerated but did not alter CSF biomarkers, brain amyloid burden, or clinical outcomes.
263.	Landén, M, et al. (author) A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors 2006 In: Psychopharmacology bulletin. - 0048-5764. ; 39:1, s. 147-66 Journal article (peer-reviewed)
264.	Landen, M, et al. (author) A placebo-controlled trial exploring the efficacy of paroxetine for the treatment of premenstrual dysphoria 2001 In: NORDIC JOURNAL OF PSYCHIATRY. - 0803-9488. ; 55:2, s. 95-95 Conference paper (other academic/artistic)
265.	Landen, M, et al. (author) A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression 1998 In: The Journal of clinical psychiatry. - 0160-6689. ; 59:12, s. 664-668 Journal article (peer-reviewed)
266.	Landen, M, et al. (author) A rapid onset of action when paroxetine is used to treat premenstrual dysphoria: A placebo-controlled trial 2004 In: NORDIC JOURNAL OF PSYCHIATRY. - 0803-9488. ; 58:2, s. 99-99 Conference paper (other academic/artistic)
267.	Landén, M, et al. (author) [Affective disorders differ in women and men. Not only prevalence but also symptoms and treatment outcome seem to be different] 2007 In: Lakartidningen. - 0023-7205. ; 104:1-2, s. 29-31 Journal article (peer-reviewed)
268.	Landen, M, et al. (author) Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform 1996 In: Dementia (Basel, Switzerland). - 1013-7424. ; 7:5, s. 273-278 Journal article (peer-reviewed)
269.	Landen, M, et al. (author) Attitudes toward transsexualism in a Swedish national survey 2000 In: Archives of sexual behavior. - 0004-0002. ; 29:4, s. 375-388 Journal article (peer-reviewed)
270.	Landén, M, et al. (author) Bytt är bytt - och kommer aldrig igen. Könsbyte för närvarande bästa hjälp för transsexuella. 2001 In: Läkartidningen. ; 30/31, s. 3322- Journal article (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 261-270 of 375

Refine your search

Type of publication: journal article (254); conference paper (115); research review (5); other publication (1)

Type of content: peer-reviewed (246); other academic/artistic (129)

Author/Editor: Landén, Mikael, 1966 (167); Landen, M (161); Lichtenstein, P. (50); Landén, NX (38); Cichon, S (34); Reif, A. (33); show more...; Rietschel, M (30); Ripke, S (28); Bellivier, F. (28); Etain, B. (28); Leboyer, M. (28); Bauer, M (27); Eriksson, E (27); Vieta, E (26); Schalling, M (26); Herms, S. (26); Alda, M. (26); Stahle, M (25); Jamain, S. (25); Breen, G (23); Mattheisen, M (22); Muller-Myhsok, B (22); Backlund, L (22); Degenhardt, F (22); Craddock, N (21); Hauser, J. (21); Martin, NG (20); Grigoroiu-Serbanescu ... (20); Westberg, L (20); Song, J. (19); Sellgren, C (19); Sonkoly, E (19); Dannlowski, U (19); Palsson, E (19); Li, D. (18); Alda, Martin (18); Sklar, P (18); Frisen, L. (18); Pfennig, A. (18); Andreassen, O. A. (18); McGuffin, P (18); Mitchell, Philip B (17); Ekman, CJ (17); Hoffmann, P (17); Jones, I. (17); Baune, B. T. (17); Kittel-Schneider, S. (17); O'Donovan, C. (17); Hultman, C. M. (17); Pivarcsi, A (17); show less...

University: Karolinska Institutet (353); University of Gothenburg (172); Umeå University (24); Uppsala University (22); Örebro University (17); Linköping University (10); show more...; Lund University (10); Chalmers University of Technology (6); Royal Institute of Technology (1); Stockholm University (1); RISE (1); show less...

Language: English (375)

Research subject (UKÄ/SCB): Medical and Health Sciences (185); Natural sciences (7); Engineering and Technology (6); Social Sciences (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view